US BROKER MOVES: IBM upgraded at UBS; KR downgraded at Wells Fargo

• Array Technologies (ARRY) upgraded from Neutral to Outperform at BNP Paribas Exane; PT USD 19
• Enphase Energy (ENPH) upgraded from Hold to Buy at Jefferies; PT USD 57 (from USD 42)
• IBM (IBM) upgraded from Sell to Neutral at UBS; PT USD 236
• Iovance Biotherapeutics (IOVA) upgraded from Market Perform to Market Outperform at Citizens; PT USD 5
• Lincoln National (LNC) upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 48
• Oracle (ORCL) upgraded from Perform to Outperform at Oppenheimer; PT USD 185
• Principal Financial (PFG) upgraded from Underweight to Equal Weight at Wells Fargo; PT USD 91
• Shoals Technologies (SHLS) upgraded from Underperform to Neutral at BNP Paribas Exane; PT USD 9
• Trex (TREX) upgraded from Hold to Buy at Loop Capital; PT USD 53 (from USD 45)

• Evolent Health (EVH) downgraded from Overweight to Sector Weight at KeyBanc
• Fox Corp (FOX) downgraded from Buy to Underperform at BofA Securities; PT USD 45 (from USD 80)
• Fox Corp (FOXA) downgraded from Buy to Underperform at BofA Securities; PT USD 45 (from USD 80)
• Grocery Outlet (GO) downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 10.50
• Kinsale Capital (KNSL) downgraded from N/A to Underperform at BMO
• Kroger (KR) downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 68
• ONEOK (OKE) downgraded from Outperform to Peerperform at Wolfe Research
• Prudential Financial (PRU) downgraded from Equal Weight to Underweight at Wells Fargo; PT USD 103
• Ryan Specialty (RYAN) downgraded from Outperform to Market Perform at BMO; PT USD 43
• Molson Coors (TAP) downgraded from Neutral to Underperform at BofA Securities; PT USD 42 (from USD 50)
• Thermon (THR) downgraded from Outperform to Market Perform at William Blair
• Tenaris (TS) downgraded from Buy to Hold at Zephirin; PT USD 45 (from USD 42)
• Workday (WDAY) downgraded from Buy to Hold at TD Cowen; PT USD 155 (from USD 200)
• Workday (WDAY) downgraded from Outperform to In Line at Evercore ISI; PT USD 160 (from USD 200)

• Angion Biomedica (ANGX) initiated at Buy at B. Riley; PT USD 7
• Aura Biosciences (AUGO) initiated at Overweight at JPMorgan; PT USD 105
• Baker Hughes (BKR) initiated at Buy at Johnson Rice; PT USD 68
• Baldwin Insurance (BWIN) initiated at Buy at TD Cowen
• CEVA (CEVA) initiated at Buy at UBS; PT USD 27
• Hasbro (HAS) initiated at Outperform at BNP Paribas Exane
• Century Therapeutics (IPSC) initiated at Buy at TD Cowen
• Live Nation (LYV) initiated at Overweight at Wells Fargo; PT USD 204
• Mattel (MAT) initiated at Neutral at BNP Paribas Exane; PT USD 17
• Ovintiv (OVV) initiated at Overweight at JPMorgan; PT USD 58
• PepGen (PEPG) initiated at Outperform at Oppenheimer; PT USD 15
• Q32 Bio (QTTB) initiated at Buy at H.C. Wainwright; PT USD 13

Today's upgrades and downgrades in key stocks show mixed sentiment, with notable upgrades for IBM at UBS and downgrades for Kroger at Wells Fargo. The implications here are significant; IBM's upgrade reflects a more favorable outlook, which could buoy investor sentiment, whereas Kroger's downgrade suggests a cautious stance on retail amid changing consumer dynamics. Watch these moves closely for sector impacts and investor positioning shifts.